Voltaren Retard

Ülke: Ermenistan

Dil: İngilizce

Kaynak: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktif bileşen:

diclofenac (diclofenac sodium)

Mevcut itibaren:

Novartis Farma S.p.A.

INN (International Adı):

diclofenac (diclofenac sodium)

Doz:

75mg

Farmasötik formu:

tablets film-coated prolonged-release

Reçete türü:

Prescription

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1.
TRADE NAME OF THE MEDICINAL PRODUCT
Voltaren
®
Retard 75mg or 100mg SR tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
The active substance is
sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (diclofenac
sodium).
Each slow release tablet contains 75mg diclofenac sodium Ph.Eur.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Slow release tablet.
Pale pink, triangular,biconvex, bevel edges tablets marked “ID” on
one face, and “CG” on the other.
in black ink.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
_Adults and Elderly_
:
Relief of all grades of pain and inflammation in a wide range of
conditions, including:
(i)
arthritic conditions: rheumatoid arthritis, osteoarthritis, ankylosing
spondylitis, acute gout,
(ii)
acute
musculo-skeletal
disorders
such
as
periarthritis
(for
example
frozen
shoulder),
tendinitis, tenosynovitis, bursitis.
(iii)
other painful conditions resulting from trauma, including fracture,
low back pain, sprains,
strains, dislocations, orthopaedic, dental and other minor surgery.
_Children_
: Voltaren
®
Retard 75mg or 100mg SR tablets are not suitable for children.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Undesirable effects may be minimised by using the lowest effective
dose for the shortest duration
necessary to control symptoms (see section 4.4 Special warnings and
precautions for use).
For oral administration
ADULTS
One tablet once or twice daily, taken whole with liquid, preferably at
meal times.
The recommended maximum daily dose of Voltaren
®
Retard is 150mg.
SPECIAL POPULATIONS
ELDERLY
(aged 65 years or above)
Although the pharmacokinetics of Voltaren
®
Retard are not impaired to any clinically relevant extent
in elderly patients, nonsteroidal anti-inflammatory drugs should be
used with particular caution in
such patients who generally are more prone to adverse reactions. In
particular it is recommended that
the lowest effective dosage be used in frail elderly patients or those
with a low body weight